| Literature DB >> 28979305 |
Tamer Awad Ali1, Gehad Genidy Mohamed2, Ghada A Yahya2.
Abstract
This article is focused on the determination of lidocaine hydrochloride as a local anaesthetic drug. A potentiometric method based on modified screen-printed and modified carbon paste ion-selective electrodes was described for the determination of lidocaine hydrochloride in different pharmaceutical preparations and biological fluids (urine and serum). It was based on potentiometric titration of lidocaine hydrochloride using modified screen-printed and carbon paste electrodes as end point indicator sensors. The influences of the paste composition, different conditioning parameters and foreign ions on the electrodes performance were investigated and response times of the electrodes were studied. The electrodes showed Nernstian response of 58.9 and 57.5 mV decade-1 in the concentration range of 1×10-7-1×10-2 and 6.2×10-7-1×10-2 mol L-1 for modified screen-printed and carbon paste electrodes, respectively. The electrodes were found to be usable within the pH range of 2.0-8.0 and 2.0-7.5, exhibited a fast response time (about 6 and 4) low detection limit (1×10-7 and 6.2×10-7 mol L-1), long lifetime (6 and 4 months) and good stability for modified screen-printed (Electrode VII) and carbon paste electrodes (Electrode III), respectively. The electrodes were successfully applied for the determination of lidocaine hydrochloride in pure solutions, pharmaceutical preparation and biological fluids (urine and serum) samples. The results obtained applying these potentiometric electrodes were comparable with British pharmacopeia. The method validation parameters were optimized and the method can be applied for routine analysis of lidocaine hydrochloride drug.Entities:
Keywords: Lidocaine hydrochloride; Modified carbon paste electrode; Modified screen-printed electrode; Pharmaceutical preparation; Urine and serum
Year: 2017 PMID: 28979305 PMCID: PMC5603859
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1Calibration graphs using (a) MCPE and (b) MSPEs sensors using TCP plasticizer.
Response characteristics of LCHC-MCPE (electrode III) and LCHC-MSPE (electrode VII) potentiometric sensors.
|
|
|
|
|---|---|---|
| Precision (%) | 0.174 | 0.093 |
|
| 57.50 ± 0.89 | 58.90 ± 0.68 |
| Correlation coefficient, r | 0.998 | 0.999 |
| Lower detection limit (mol L-1) | 6.2 × 10-7 | 1 × 10-7 |
| limit of quantification (mol L-1) | 14.45 × 10-7 | 3.33 × 10-7 |
| Response time (s) | 6 | 4 |
| Working pH range | 2 – 7.5 | 2 – 8.0 |
| Usable range (mol L-1) | 6.2×10-7 - 1×10-2 | 1×10-7 - 1.0×10-2 |
| SD of slope (mV decade− 1) | 0.207 | 0.110 |
|
| 238.42 ± 1.15 | 285.01 ± 1.03 |
| Life time (months) | 4 | 6 |
| Accuracy (%) | 99.74 | 99.86 |
The slope and intercept of the calibration curve
Figure 2Effect of ionophore contents on (a) MCPE and (b) MSPE sensors using TCP plasticizer.
Figure 3Effect of plasticizer type on the performance of (a) MCPE (electrode III) and (b) MSPE (electrode VII) sensors.
Effect of soaking time on the performance of MCPE and MSPE potentiometric sensors.
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| |
| 24 h | 2.92 | 97.33 | 24 | 19 | 50 | 2.86 | 95.33 | 12 | 9 | 25 | |
| Without | 2.99 | 99.67 | 127 | 125 | 312.5 | 2.97 | 99.00 | 113 | 108 | 275 | |
| 5 min | 2.98 | 99.33 | 119 | 114 | 287.5 | 2.98 | 99.33 | 130 | 125 | 312.5 | |
| 10 min | 2.97 | 99.00 | 91 | 86 | 217.5 | 2.99 | 99.67 | 131 | 128 | 320 | |
| 15 min. | 2.95 | 98.33 | 79 | 76 | 192.5 | 2.98 | 99.33 | 110 | 105 | 265 | |
| 30 min. | 2.94 | 98.00 | 59 | 53 | 101 | 2.97 | 99.00 | 79 | 74 | 198 | |
| 1 h | 2.95 | 98.33 | 38 | 35 | 87.5 | 2.95 | 98.33 | 45 | 42 | 105 | |
| 2 h | 2.93 | 97.67 | 29 | 23 | 63 | 2.89 | 96.33 | 20 | 16 | 42.5 | |
Figure 4Effect of pH of the test solution on MCPEs [(a) electrode (III) and (b) electrode (A)] and MSPEs [(c) electrode (VII) and (d) electrode (B)].
Figure 5Effect of temperature on the performance of MCPEs [(a) electrode (III) and (b) electrode (A)] and MSPEs [(c) electrode (VII) and (d) electrode (B)].
Potentiometric selectivity coefficients of some interfering ions using CMCPEs (electrodes III and A) and MSPEs (electrodes VII and B).
|
|
| |||
|---|---|---|---|---|
|
|
| |||
|
|
|
|
| |
| Cr3+ | 6.1×10-5 | 4.7 ×10-6 | 3.2×10-5 | 3.5×10-6 |
| Ba2+ | 4.4×10-5 | 2.6×10-5 | 2.1×10-5 | 1.1×10-5 |
|
| 8.8×10-6 | 5.2×10-6 | 3.5×10-6 | 1.9×10-6 |
| Co2+ | 9.4×10-5 | 7.4×10-6 | 6.5×10-5 | 5.7×10-6 |
| Mg2+ | 5.7×10-5 | 8.2×10-6 | 4.8×10-5 | 7.6×10-6 |
| Ca2+ | 6.6×10-6 | 5.9×10-6 | 4.3×10-6 | 4.0×10-6 |
| Zn2+ | 7.5×10-6 | 5.1×10-6 | 6.8×10-6 | 9.3×10-7 |
| Cu2+ | 8.1×10-5 | 8.0×10-5 | 6.3×10-5 | 5.3×10-5 |
| Mn2+ | 4.6×10-5 | 2.4×10-5 | 7.2×10-6 | 3.8×10-6 |
|
| ||||
| Glycine | 4.9×10-4 | 3.2×10-4 | 1.7×10-5 | 0.9×10-5 |
| Fructose | 8.4×10-3 | 6.2×10-3 | 4.3×10-3 | 2.0×10-3 |
| Glucose | 7.4×10-3 | 5.0×10-3 | 2.2×10-4 | 1.0×10-4 |
| Sucrose | 3.2×10-3 | 6.2×10-3 | 2.4×10-4 | 5.9×10-4 |
| Maltose | 0.5×10-4 | 1.5×10-4 | 3.2×10-4 | 6.8×10-4 |
| Lactose | 7.1×10-3 | 6.5×10-3 | 4.7×10-3 | 2.7×10-3 |
| Starch | 8.6×10-3 | 7.0×10-3 | 5.3×10-3 | 1.4×10-3 |
Figure 6Dynamic response time of LCHC sensors of MCPEs [(a) electrode (III) and (b) electrode (A)] and MSPEs [(c) electrode (VII) and (d) electrode (B)].
Figure 7Life time of LCHC ion selective electrodes (a) MCPE [electrodes (III)] (b) MSPE [electrodes (VII)].
Potentiometric determination of LCHC in pharmaceutical formulations using MCPEs (electrodes III and A) and MSPEs (electrodes VII and B).
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |
| 1 | 0.496 | 0.495 | 0.498 | 0.497 | 0.503 | 0.983 | 1.007 | 0.647 | 0.527 | 0.236 |
| 2 | 0.493 | 0.495 | 0.497 | 0.499 | 0.510 | 0.957 | 1.064 | 1.036 | 0.136 | 0.095 |
| 3 | 0.990 | 0.994 | 0.996 | 0.999 | 0.998 | 1.045 | 1.074 | 0.973 | 0.562 | 0.747 |
SD values for Pharmaceutical Preparation (British Pharmacopeia = 0.213-0.789), (electrode III = 0.154-0.634) (electrode A = 0.125-0.603), (electrode VII = 0.073- 0.562) and (electrode B = 0.015- 0.078).
F-test = (electrode III = 1.7 – 2.1), (electrode A = 0.5 – 1.2), (electrode VII = 0.3 – 1.0) and (electrode B = 0.09 – 0.8). (Tabulated F value at 95% confidence limit = 6.39 for n = 4).
t-test = (electrode III = 1.8 – 2.3), (electrode A = 0.7 – 2.1), (electrode VII = 0.6 – 1.8) and (electrode B = 0.12 – 1.2). (Tabulated t value at 95% confidence limit = 2.776 for n = 4).
Samples 1, 2 and 3 were lidocaine gel, farco-Caine oint and lidosine oint, respectively.
Determination of LCHC in spiked urine and human serum using MCPEs (Sensor III) and MSPEs (Sensor VII).
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| urine | Mean recovery (%) | 99.12 | 98.77 | 97.98 | 99.60 | 99.00 | 98.80 |
| N | 5 | 5 | 5 | 5 | 5 | 5 | |
| Variance | 0.85 | 0.72 | 0.80 | 0.78 | 0.57 | 0.63 | |
| RSD (%) | 0.38 | 0.53 | 0.81 | 0.42 | 0.51 | 0.67 | |
| serum | Mean recovery (%) | 99.44 | 99.13 | 99.00 | 98.98 | 99.21 | 97.78 |
| N | 5 | 5 | 5 | 5 | 5 | 5 | |
| Variance | 0.47 | 0.56 | 0.72 | 0.34 | 0.29 | 0.49 | |
| RSD (%) | 0.62 | 0.53 | 0.81 | 0.44 | 0.37 | 0.65 | |
Evaluation of intra- and inter-days precision and accuracy of MCPEs (electrodes III and A) and MSPEs (electrodes VII and B) in Pharmaceutical Preparation and water samples.
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |||
| III | Pure LCHC | 0.25 | 0.249 | 99.60 | 0.009 | 0.563 | 0.248 | 99.20 | 0.012 | 0.753 |
| 0.50 | 0.498 | 99.60 | 0.007 | 0.215 | 0.495 | 99.00 | 0.003 | 0.895 | ||
| Sample 2 | 0.50 | 0.495 | 99.00 | 0.011 | 0.346 | 0.494 | 98.80 | 0.052 | 0.579 | |
| 1.00 | 0.995 | 99.50 | 0.013 | 0.532 | 0.996 | 99.60 | 0.041 | 0.421 | ||
| Sample 3 | 0.50 | 0.491 | 98.20 | 0.126 | 1.062 | 0.490 | 98.00 | 0.089 | 0.989 | |
| 1.00 | 0.994 | 99.40 | 0.012 | 0.361 | 0.992 | 99.20 | 0.037 | 1.035 | ||
| A | Pure LCHC | 0.25 | 0.248 | 99.20 | 0.013 | 0.458 | 0.247 | 98.80 | 0.153 | 0.892 |
| 0.50 | 0.497 | 99.40 | 0.037 | 0.857 | 0.496 | 99.20 | 0.816 | 0.937 | ||
| Sample 2 | 0.25 | 0.243 | 97.20 | 0.062 | 1.521 | 0.240 | 96.00 | 0.062 | 2.024 | |
| 0.50 | 0.492 | 98.40 | 0.048 | 1.253 | 0.491 | 98.20 | 0.073 | 2.009 | ||
| Sample 3 | 0.50 | 0.493 | 98.60 | 0.028 | 1.012 | 0.490 | 98.00 | 0.098 | 1.014 | |
| 1.00 | 0.991 | 99.10 | 0.009 | 0.162 | 0.993 | 99.30 | 0.003 | 0.098 | ||
| VII | Pure LCHC | 0.25 | 0.249 | 99.60 | 0.009 | 0.087 | 0.251 | 100.4 | 0.005 | 0.173 |
| 0.50 | 0.501 | 100.2 | 0.003 | 0.058 | 0.500 | 100.0 | 0.002 | 0.132 | ||
| Sample 2 | 0.50 | 0.490 | 98.00 | 0.013 | 0.910 | 0.488 | 97.60 | 0.073 | 1.953 | |
| 1.00 | 0.989 | 98.90 | 0.062 | 1.006 | 0.985 | 98.50 | 0.036 | 1.457 | ||
| Sample 3 | 0.50 | 0.489 | 97.80 | 0.931 | 1.424 | 0.487 | 97.40 | 0.875 | 1.741 | |
| 1.00 | 0.988 | 98.80 | 0.427 | 1.842 | 0.986 | 98.60 | 0.655 | 1.952 | ||
| B | Pure LCHC | 0.25 | 0.249 | 99.60 | 0.010 | 0.173 | 0.248 | 99.20 | 0.012 | 0.967 |
| 0.50 | 0.499 | 99.80 | 0.005 | 0.098 | 0.502 | 100.4 | 0.003 | 0.084 | ||
| Sample 2 | 0.50 | 0.479 | 95.80 | 0.063 | 1.261 | 0.486 | 97.20 | 0.032 | 1.077 | |
| 1.00 | 0.987 | 98.70 | 0.162 | 1.075 | 0.985 | 98.50 | 0.043 | 1.025 | ||
| Sample 3 | 0.50 | 0.491 | 98.20 | 0.091 | 0.936 | 0.489 | 97.80 | 0.668 | 1.067 | |
| 1.00 | 0.993 | 99.30 | 0.002 | 0.231 | 0.991 | 99.10 | 0.036 | 0.993 | ||
Sample 2 was farco-Caine oint.
Sample 3 was lidosine oint.
Number of replicates = 5.
Comparing some of the LCHC-MCPE (electrode III) and LCHC-MSPE (electrode VII) characteristics with some of the previously reported LCHC-ISEs.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Proposed electrode | 57.50 | 6 | 2.0-7.5 | 4 | 6.2×10-7 - 1×10-2 | 6.2×10-7 |
| Proposed electrode | 58.90 | 4 | 2.0-8.0 | 6 | 1.0 × 10-7 – 1.0 × 10-2 | 1.0 × 10-7 |
| 37 | 60.10 | < 10 | 5.0 - 9.5 | 3.5 | 1.0 × 10-4 - 1.0 × 10-1 | 6.3 × 10−5 |
| 38 | 57.10 | < 10 | 2.0 – 8.0 | 6 | 1.0 × 10-5 – 1.0 × 10-3 | 2.0 × 10-6 |
| 39 (Electrode A) | 58.20 | - | 2.0-7.5 | - | 1.0 × 10-4 - 1.0 × 10-1 | 2.5 × 10-5 |
| 39 (Electrode B) | 57.30 | - | 2.0-7.5 | - | 3.2 × 10-5 - 1.0 × 10-1 | 1.0 × 10-5 |